• Home
  • Our aims
  • Services
  • References
  • R&D projects
    • SCHIZO Biomarker project
    • Epigenetic kit development
    • Developing tearproteomic depleting kit
    • Micro RNA measuring with UPL based technique
    • The Commercialisation of Transglutaminase
  • About us
  • Contact us
  • News
  • Hun
  • Eng
Services
- Functional genomic analysis services
- Epigenetic and epigenomic analysis service
References
- Partners
- Publications
- Conferences
R&D Projects
- SCHIZO Biomarker project
- Epigenetic kit development
- Tearproteomic depletion kit development
Print
29/09/10

SCHIZO project - further progress on the project

Begin tests on human samples

schizo08_logo

RNA samples from schizophrenic patients have been tested. In SCHIZO Biomarker we are to isolate RNA from appr. 500 schizophrenic patients. The QC of RNAs are measured by Agilent Bioanalizer and validated by an independent laboratory. Now, we performed Affymetrix test arrays and the results verified that we can start with scanning of human samples.

Are you interested in our Agilent Bioanalizer services? Do you need biomarkers? Read more about these solutions!

 
Honlapkészítés Debrecen

Contact us

UD-GenoMed Medical Genomic Technologies Ltd.

University of Debrecen, Medical and Health Science Center
Debrecen Clinical Genomic Center

4032 Debrecen, Hungary, Nagyerdei krt. 98.
Theoretical Building Room 211.

Postal address: 4012 Debrecen, Hungary, Pf. 52.
Phone: +36-52-411-717 (ext. 54616) or +3652-314-372
Email: info@ud-genomed.hu
Fax: +3652-314-372

Chief Executive Officer: Gábor Zahuczky, M.Sc., Ph.D.

Phone: +36-52-411-717 (ext. 50219)
Mobile: +36-30-494-6496
Email: zahu@ud-genomed.hu